– Bloomberg
Eli Lilly To Acquire Small Company DICE Therapeutics Focused On Autoimmune Diseases For $2B
Eli Lilly And Co (NYSE: LLY) has agreed to acquire DICE Therapeutics Inc (NASDAQ: DICE), a biopharmaceutical company that leverages its proprietary DELSCAPE technology platform to develop oral therapeutic ca